Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
03.08.2023 - Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today reported financial results for the second quarter ended ...
United Kingdom Alethia Young Exchange Commission German Cancer Research Center Credit Suisse Drug Administration
Source: wallstreet-online.de